Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000250 · ClinicalTrials.gov registry record · Phase 2
Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2
A Phase 2 study of Substance-Related Disorders and Opioid-Related Disorders, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT00000250 is a Phase 2 study of Substance-Related Disorders and Opioid-Related Disorders that has completed, run by University of Chicago. The registered enrollment target is 12 participants, below the 1,521-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00000250, a Phase 2 study of Substance-Related Disorders and Opioid-Related Disorders, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To evaluate: cold water immersion modulates the reinforcing effects of nitrous oxide in healthy volunteers.
Conditions Studied
Interventions
- DRUG 0% N2O
- DRUG 40% N2O
Study Locations (1)
Illinois
- University of Chicago, Anesthesia & Critical Care - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 1993-12 |
| Est. Completion | 1995-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000250
The ClinicalTrials.gov registry entry for NCT00000250 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,521-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (99% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which 0% N2O is the first listed.
NCT00000250 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00000250 about?
NCT00000250 is a clinical study titled "Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2". The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To evaluate: cold water immersion modulat...
What is the current status of trial NCT00000250?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 1993-12. Estimated completion is 1995-05.
What conditions does trial NCT00000250 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Opioid-Related Disorders.
What interventions are being tested in trial NCT00000250?
The interventions under investigation include: 0% N2O (DRUG), 40% N2O (DRUG).
Who is sponsoring clinical trial NCT00000250?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000250 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder
RECRUITING · Phase 2
-
GLP-1R Agonist Treatment for Opioid Use Disorder
RECRUITING · Phase 2
-
The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1
COMPLETED · Phase 2
-
Buprenorphine Maintenance for Opiate Dependence - 6
COMPLETED · Phase 2
-
A Laboratory Model for Heroin Abuse Medications - 8
COMPLETED · Phase 2
-
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.